Clinical Trial Update: MEK Inhibitors for the Treatment of Hypertrophic Cardiomyopathy in Patients With RASopathies [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial is evaluating MEK inhibitors for hypertrophic cardiomyopathy in patients with RASopathies, including Noonan syndrome, and is currently …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypertrophic Cardiomyopathy
• Noonan Syndrome

Snippet

Sponsor: Medical University of Warsaw | Conditions: Cardiomegaly, Noonan Syndrome | Phase 2 | Status: RECRUITING